RAD51 and breast angiosarcoma: As presented in Figure 8, compared to the control group, the expression levels of AURKA, BUB1, CDK1, RAD51, and TOP2A were significantly upregulated in the BA group (P < 0.01), consistent with the bioinformatics analysis.